Literature DB >> 20803327

Tumour visualization in a murine model by time-delayed fluorescence of sulphonated aluminium phthalocyanine.

R Cubeddu1, G Canti, P Taroni, G Valentini.   

Abstract

Mice bearing the MS-2 fibrosarcoma were administered 0.25, 0.5 or 1 mg kg(-1) body weight (b.w.) of sulphonated aluminium phthalocyanine (AlS(2)Pc) (with average degree of sulphonation of 2.1), and time-gated fluorescence images were acquired up to 6 h after the injection. Different excitation wavelengths (610, 650 and 670 nm) were tested. Red light excitation and 3 ns delayed detection allow one to minimize natural fluorescence and scattered laser light, respectively. The best conditions for tumour detection are reached under either 650 or 670 nm Excitation, 2-4 h after the administration of either 0.5 or 1 mg kg(-1) b.w. of AlS(2)Pc. In these situations, the average fluorescence contrast between tumour area and surrounding healthy tissue is > 2, providing a clear identification of the pathological region. However, tumour localization is possible even after the injection of 0.25 mg kg(-1) b.w. of sensitizer. In conclusion, under low power excitation (< 100MuW cm(-2)), the technique allows real time detection of an intradermal tumour with good contrast.

Entities:  

Year:  1997        PMID: 20803327     DOI: 10.1007/BF02765100

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  18 in total

1.  Medical diagnostic system based on simultaneous multispectral fluorescence imaging.

Authors:  S Andersson-Engels; J Johansson; S Svanberg
Journal:  Appl Opt       Date:  1994-12-01       Impact factor: 1.980

Review 2.  Phthalocyanines as photodynamic sensitizers.

Authors:  I Rosenthal
Journal:  Photochem Photobiol       Date:  1991-06       Impact factor: 3.421

3.  Skin optics.

Authors:  M J van Gemert; S L Jacques; H J Sterenborg; W M Star
Journal:  IEEE Trans Biomed Eng       Date:  1989-12       Impact factor: 4.538

Review 4.  Photosensitizers: therapy and detection of malignant tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-06       Impact factor: 3.421

5.  A fluorescence imaging device for endoscopic detection of early stage cancer--instrumental and experimental studies.

Authors:  R Baumgartner; H Fisslinger; D Jocham; H Lenz; L Ruprecht; H Stepp; E Unsöld
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

6.  Ratioing fluorometer probe for localizing carcinoma in situ in bronchi of the lung.

Authors:  O J Balchum; A E Profio; N Razum
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

7.  Ex vivo optical properties of human colon tissue.

Authors:  R Marchesini; E Pignoli; S Tomatis; S Fumagalli; A E Sichirollo; S Di Palma; M Dal Fante; P Spinelli; A C Croce; G Bottiroli
Journal:  Lasers Surg Med       Date:  1994       Impact factor: 4.025

8.  In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model.

Authors:  R Cubeddu; G Canti; M Musolino; A Pifferi; P Taroni; G Valentini
Journal:  J Photochem Photobiol B       Date:  1996-07       Impact factor: 6.252

9.  Laser-induced fluorescence in malignant and normal tissue of rats injected with benzoporphyrin derivative.

Authors:  S Andersson-Engels; J Ankerst; J Johansson; K Svanberg; S Svanberg
Journal:  Photochem Photobiol       Date:  1993-06       Impact factor: 3.421

10.  Time-gated fluorescence imaging for the diagnosis of tumors in a murine model.

Authors:  R Cubeddu; G Canti; P Taroni; G Valentini
Journal:  Photochem Photobiol       Date:  1993-03       Impact factor: 3.421

View more
  2 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.